PFE - Pfizer Inc.
Close
29.01
0.290 1.000%
Share volume: 37,110,584
Last Updated: Fri 30 Aug 2024 10:02:13 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$28.72
0.29
1.01%
View ratios
| Fiscal Date | 2022-07-03 | 2022-10-02 | 2022-12-31 | 2023-04-02 | 2023-07-02 | 2023-10-01 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-10 | 2022-11-09 | 2023-02-23 | 2023-05-10 | 2023-08-09 | 2023-11-08 | 2024-02-22 | 2024-05-08 | |
| Assets | |||||||||
| Total Assets | 195.289 B | 195.352 B | 197.203 B | 195.618 B | 220.169 B | 215.022 B | 226.501 B | 221.095 B | |
| Current Assets | 67.466 B | 70.405 B | 51.259 B | 50.078 B | 73.348 B | 74.012 B | 43.333 B | 42.414 B | |
| Inventories | 10.454 B | 9.513 B | 8.981 B | 9.541 B | 10.310 B | 10.204 B | 10.189 B | 10.892 B | |
| Other Current Assets | 8.553 B | 8.693 B | 8.594 B | 8.260 B | 8.022 B | 8.541 B | 9.277 B | 8.605 B | |
| Short Term Investments | 8.553 B | 8.693 B | 8.594 B | 8.260 B | 8.022 B | 8.541 B | 9.277 B | 8.605 B | |
| Total Receivables | 15.155 B | 16.076 B | 10.952 B | 12.305 B | 10.231 B | 11.086 B | 11.177 B | 10.989 B | |
| Current Cash | 33.304 B | 36.123 B | 22.732 B | 19.972 B | 44.785 B | 44.181 B | 12.690 B | 11.928 B | |
| Total Non-current Assets | 127.823 B | 124.947 B | 145.944 B | 145.540 B | 146.821 B | 141.010 B | 183.168 B | 178.681 B | |
| Property Plant Equipment | 15.244 B | 15.441 B | 16.274 B | 17.052 B | 17.488 B | 17.862 B | 18.940 B | 18.803 B | |
| Other Assets | 14.661 B | 18.026 B | 19.856 B | 20.267 B | 21.289 B | 17.158 B | 16.177 B | 16.139 B | |
| Intangible Assets | 29.065 B | 28.151 B | 43.370 B | 42.002 B | 41.406 B | 40.224 B | 64.900 B | 62.829 B | |
| Goodwill | 49.891 B | 49.441 B | 51.375 B | 51.476 B | 51.572 B | 51.527 B | 67.783 B | 69.297 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 195.289 B | 195.352 B | 197.203 B | 195.618 B | 220.169 B | 215.022 B | 226.501 B | 221.095 B | |
| Total liabilities | 108.081 B | 102.717 B | 101.544 B | 94.647 B | 121.147 B | 118.086 B | 137.486 B | 128.812 B | |
| Total current liabilities | 47.410 B | 44.313 B | 42.139 B | 36.562 B | 34.646 B | 31.136 B | 47.794 B | 40.497 B | |
| Accounts Payable | 6.208 B | 6.267 B | 6.809 B | 6.123 B | 6.081 B | 5.338 B | 6.710 B | 5.591 B | |
| Other liabilities | 25.558 B | 24.900 B | 25.242 B | 25.048 B | 23.639 B | 24.507 B | 27.240 B | 25.801 B | |
| Current long term debt | 5.990 B | 4.040 B | 2.945 B | 4.188 B | 3.985 B | 2.548 B | 10.350 B | 8.232 B | |
| Long term debt | 34.294 B | 32.629 B | 32.884 B | 31.704 B | 61.356 B | 61.048 B | 61.538 B | 61.307 B | |
| Other liabilities | 25.558 B | 24.900 B | 25.242 B | 25.048 B | 23.639 B | 24.507 B | 27.240 B | 25.801 B | |
| Minority interest | 261.000 M | 259.000 M | 256.000 M | 266.000 M | 274.000 M | 270.000 M | 274.000 M | 276.000 M | |
| Total Shareholder equity | 87.209 B | 92.632 B | 95.661 B | 100.971 B | 99.019 B | 96.934 B | 89.014 B | 92.282 B | |
| Common stock | 5.593 B | 5.607 B | 5.615 B | 5.634 B | 5.646 B | 5.646 B | 5.646 B | 5.657 B | |
| Retained earnings | 116.608 B | 122.967 B | 125.656 B | 131.102 B | 128.796 B | 126.411 B | 118.353 B | 121.318 B |